Priya Pais

Priya Pais

Auto-generated profile, based on publicly available information

Priya Pais

Department of Pediatric Nephrology, St John's Medical College, St John's National Academy of Health Sciences, Bengaluru (Bangalore), India

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2022 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
SMSitarah Mathias
Sitarah Mathias
LGLarry A. Greenbaum
Larry A. Greenbaum
ASA.M. Shubha
A.M. Shubha
JRJohn A. Michael Raj
John A. Michael Raj
KDKanishka Das
Kanishka Das
PPPriya Pais
Priya Pais

15 October 2020 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
PPPriya Pais
Priya Pais
TBTom Blydt-Hansen
Tom Blydt-Hansen
JRJohn A. Michael Raj
John A. Michael Raj
LSLuca Dello Strologo
Luca Dello Strologo
AIArpana Iyengar
Arpana Iyengar

23 August 2017 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
DSDavid T. Selewski
David T. Selewski
JTJonathan P. Troost
Jonathan P. Troost
DCDanyelle Cummings
Danyelle Cummings
SMSusan F. Massengill
Susan F. Massengill
RGRasheed A. Gbadegesin
Rasheed A. Gbadegesin
DGDebbie S. Gipson
Debbie S. Gipson
Nephrotic syndrome represents a condition in pediatric nephrology typified by a relapsing and remitting course, proteinuria and the presence of edema. The PROMIS measures have previously been studied and validated in cross-sectional studies of children with nephrotic syndrome. This study was designed to longitudinally validate the PROMIS measures in pediatric nephrotic syndrome. One hundred twenty seven children with nephrotic syndrome between the ages of 8 and 17 years participated in this prospective cohort study. Patients completed a baseline assessment while their nephrotic syndrome was active, a follow-up assessment at the time of their first complete proteinuria remission or study month 3 if no remission occurred, and a final assessment at study month 12. Participants completed six PROMIS measures (Mobility, Fatigue, Pain Interference, Depressive Symptoms, Anxiety, and Peer Relationships), the PedsQL version 4.0, and two global assessment of change items. Disease status was classified at each assessment: nephrotic syndrome active in 100% at baseline, 33% at month 3, and 46% at month 12. The PROMIS domains of Mobility, Fatigue, Pain Interference, Depressive Symptoms, and Anxiety each showed a significant overall improvement over time (p < 0.001). When the PROMIS measures were compared to the patients’ global assessment of change, the domains of Mobility, Fatigue, Pain Interference, and Anxiety consistently changed in an expected fashion. With the exception of Pain Interference, change in PROMIS domain scores did not correlate with changes in disease activity. PROMIS domain scores were moderately correlated with analogous PedsQL domain scores. This study demonstrates that the PROMIS Mobility, Fatigue, Pain Interference, and Anxiety domains are sensitive to self-reported changes in disease and overall health status over time in children with nephrotic syndrome. The lack of significant anchoring to clinically defined nephrotic syndrome disease active and remission status may highlight an opportunity to improve the measurement of HRQOL in children with nephrotic syndrome through the development of a nephrotic syndrome disease-specific HRQOL measure.

11 March 2022 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PPPriya Pais
Priya Pais
AWAaron Wightman
Aaron Wightman
Children with kidney failure require kidney replacement therapy (KRT), namely maintenance dialysis and kidney transplant. Adequate kidney failure care consists of KRT or conservative treatment with palliative care. In the context of kidney failure, children depend on parents who are their surrogate decision-makers, and the pediatric nephrology team for taking decisions about KRT or conservative care. In this paper, we discuss the ethical challenges that arise relating to such decision-making, from a global perspective, using the framework of pediatric bioethics. While many ethical dilemmas in the care of children with KRT are universal, the most significant ethical dilemma is the inequitable access to KRT in low & middle income countries (LMICs) where rates of morbidity and mortality depend on the family's ability to pay. Children with kidney failure in LMICs have inadequate access to maintenance dialysis, timely kidney transplant and palliative care compared to their counterparts in high income countries. Using case vignettes, we highlight how these disparities place severe burdens on caregivers, resulting in difficult decision-making, and lead to moral distress among pediatric nephrologists. We conclude with key action points to change this status-quo, the most important being advocacy by the global pediatric nephrology community for better access to affordable kidney failure care for children.

22 April 2020 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
PPPriya Pais
Priya Pais
LSLuca Dello Strologo
Luca Dello Strologo
AIArpana Iyengar
Arpana Iyengar
VVVasanthakumar Velusamy
Vasanthakumar Velusamy
LGLarry A. Greenbaum
Larry A. Greenbaum

16 August 2007 in Neonatology
Verified
Journal Article
Closed access
EJEunice John
Eunice John
PPPriya Pais
Priya Pais
NFNicholas Furtado
Nicholas Furtado
ACAnthony Chin
Anthony Chin
JRJayant Radhakrishnan
Jayant Radhakrishnan
UBUlf H. Beier
Ulf H. Beier
Background: Gram-negative sepsis in newborns is associated with high mortality and morbidity. Lipopolysaccharide (LPS) and cytokines released upon exposure to gram-negative sepsis are well known to be involved in the pathophysiology. Objective: In this report we investigate cytokine release, hemodynamic, and renal function induced by LPS in a newborn animal model with the intention to further examine early changes in gram-negative sepsis. Methods: Five 7- to 10-day-old domestic piglets were anesthetized and catheters placed in the jugular veins, left ventricle, and femoral artery. Urine output was monitored via suprapubic cystostomy. Mean arterial pressure, heart rate, and arterial blood gases were continuously monitored. Thirty minutes after line placement and obtaining baseline values, 0.06 µg/kg LPS were administered intravenously. One, 2, and 3 h later samples were taken to monitor tumor necrosis factor (TNF)-α, interleukin (IL)-1β, endothelin, and nitric oxide (NO)/nitrate via ELISA. In addition, blood flow was assessed by the microsphere method. Results: Our data show an initial surge of TNF-α and IL-1β at 1 h after exposure to LPS. NO/nitrate, endothelin, and hemodynamic as well as metabolic changes became apparent mostly 3 h after exposure, by which time TNF-α and IL-1β fell back to baseline. Conclusions: Our sepsis model suggests a brief initial TNF-α and IL-1β surge following LPS challenge; however, their effects become apparent by the time the levels are already subsiding. The emergence of vasoactive substances, NO and endothelin, precedes the first substantial clinical symptoms.